PURPOSE: Preimplantation Genetic Diagnosis (PGD) has proven to be a useful reproductive option for carriers of some chromosome rearrangements. The data presented in this study compares the impact of one versus two blastomere biopsy on the likelihood of achieving a PGD result, as well as the effect on subsequent embryo development and clinical outcomes. METHODS: IVF-PGD couples had either one or two blastomeres biopsied from all embryos with ≥7 blastomeres on day 3 post oocyte collection. These blastomeres were assessed for the specific chromosome rearrangement using Fluorescent In-situ Hybridisation (FISH). Further embryo development was monitored on days 4 and 5. Clinical outcomes were assessed retrospectively. RESULTS: The data shows that statistically more embryos achieved a PGD result following two blastomere biopsy, compared with one blastomere biopsy (92 % versus 88 %, respectively). Furthermore it was found that embryo development and clinical outcomes were similar between the two biopsy groups. CONCLUSIONS: Based on this analysis it appears that the biopsy of two blastomeres from embryos with ≥7 blastomeres on day 3 is a valid and successful approach for couples presenting for IVF-PGD for a chromosome rearrangement.
PURPOSE: Preimplantation Genetic Diagnosis (PGD) has proven to be a useful reproductive option for carriers of some chromosome rearrangements. The data presented in this study compares the impact of one versus two blastomere biopsy on the likelihood of achieving a PGD result, as well as the effect on subsequent embryo development and clinical outcomes. METHODS:IVF-PGD couples had either one or two blastomeres biopsied from all embryos with ≥7 blastomeres on day 3 post oocyte collection. These blastomeres were assessed for the specific chromosome rearrangement using Fluorescent In-situ Hybridisation (FISH). Further embryo development was monitored on days 4 and 5. Clinical outcomes were assessed retrospectively. RESULTS: The data shows that statistically more embryos achieved a PGD result following two blastomere biopsy, compared with one blastomere biopsy (92 % versus 88 %, respectively). Furthermore it was found that embryo development and clinical outcomes were similar between the two biopsy groups. CONCLUSIONS: Based on this analysis it appears that the biopsy of two blastomeres from embryos with ≥7 blastomeres on day 3 is a valid and successful approach for couples presenting for IVF-PGD for a chromosome rearrangement.
Authors: Veerle Goossens; Martine De Rycke; Anick De Vos; Catherine Staessen; An Michiels; Willem Verpoest; André Van Steirteghem; Catherine Bertrand; Inge Liebaers; Paul Devroey; Karen Sermon Journal: Hum Reprod Date: 2007-12-22 Impact factor: 6.918
Authors: Serena Emiliani; Eric Gonzalez-Merino; Marc Van Den Bergh; Daniel Delneste; Yvon Englert; Marc Abramowicz Journal: Hum Reprod Date: 2002-11 Impact factor: 6.918
Authors: A De Vos; C Staessen; M De Rycke; W Verpoest; P Haentjens; P Devroey; I Liebaers; H Van de Velde Journal: Hum Reprod Date: 2009-09-21 Impact factor: 6.918
Authors: C E Beyer; T Osianlis; K Boekel; E Osborne; L Rombauts; J Catt; V Kralevski; B S Aali; L Gras Journal: Hum Reprod Date: 2009-01-30 Impact factor: 6.918
Authors: Danilo Cimadomo; Antonio Capalbo; Filippo Maria Ubaldi; Catello Scarica; Antonio Palagiano; Rita Canipari; Laura Rienzi Journal: Biomed Res Int Date: 2016-01-28 Impact factor: 3.411